Health and Human Services Secretary Robert Kennedy Jr. defended proposed 2026 budget reductions during separate House and ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...